Correlation Between Sanofi ADR and GSK Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sanofi ADR and GSK Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanofi ADR and GSK Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sanofi ADR and GSK plc, you can compare the effects of market volatilities on Sanofi ADR and GSK Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanofi ADR with a short position of GSK Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanofi ADR and GSK Plc.

Diversification Opportunities for Sanofi ADR and GSK Plc

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Sanofi and GSK is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi ADR and GSK plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GSK plc and Sanofi ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanofi ADR are associated (or correlated) with GSK Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GSK plc has no effect on the direction of Sanofi ADR i.e., Sanofi ADR and GSK Plc go up and down completely randomly.

Pair Corralation between Sanofi ADR and GSK Plc

Considering the 90-day investment horizon Sanofi ADR is expected to generate 0.4 times more return on investment than GSK Plc. However, Sanofi ADR is 2.53 times less risky than GSK Plc. It trades about -0.47 of its potential returns per unit of risk. GSK plc is currently generating about -0.21 per unit of risk. If you would invest  5,436  in Sanofi ADR on August 28, 2024 and sell it today you would lose (601.00) from holding Sanofi ADR or give up 11.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Sanofi ADR  vs.  GSK plc

 Performance 
       Timeline  
Sanofi ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sanofi ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
GSK plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GSK plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Sanofi ADR and GSK Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sanofi ADR and GSK Plc

The main advantage of trading using opposite Sanofi ADR and GSK Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanofi ADR position performs unexpectedly, GSK Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GSK Plc will offset losses from the drop in GSK Plc's long position.
The idea behind Sanofi ADR and GSK plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios